Literature DB >> 21609909

The possible contribution of angiitis to the onset of benign paroxysmal positional vertigo (BPPV).

Fumiyuki Goto1, Ken Hayashi, Takanobu Kunihiro, Kaoru Ogawa.   

Abstract

OBJECTIVE: The aim was to evaluate the oxidative stress and the angiitis in patients with BPPV.
METHOD: Patients with benign paroxysmal positional vertigo (BPPV) within 14 days of onset were analyzed. The level of diacron reactive oxygen metabolites (d-ROM) and circulating soluble vascular cell adhesion molecule 1 (VCAM-1), were evaluated. As a treatment the patients were taught to perform the Brandt-Daroff exercise at home by themselves. The prognosis of BPPV, which is measured as the time until the disappearance of positional nystagmus by a physician during the outpatient visit each week, the relation among the level of oxygen metabolites, vascular molecule and the duration until remission were analyzed.
RESULTS: The patients who required longer time for the disappearance of positional nystagmus showed high d-ROM and VCAM levels, whereas those who required shorter time for remission showed lower d-ROM and VCAM levels.
CONCLUSION: There is an increased expression of VCAM-1 and d-ROM confirming the existence of an angiitis and supporting the vascular involvement in BPPV. The identification of the high levels of d-ROM and VCAM-1 can open the way to selective pharmacological treatments able to correct the oxidative stress and activation of endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21609909

Source DB:  PubMed          Journal:  Int Tinnitus J        ISSN: 0946-5448


  9 in total

1.  Oxidative stress and heart rate variability in patients with vertigo.

Authors:  Keiichiro Ohara; Yoshiaki Inoue; Yuka Sumi; Miki Morikawa; Shigeru Matsuda; Ken Okamoto; Hiroshi Tanaka
Journal:  Acute Med Surg       Date:  2014-12-11

2.  Prevention of Recurrent Benign Paroxysmal Positional Vertigo: The Role of Combined Supplementation with Vitamin D and Antioxidants.

Authors:  Giacinto Asprella Libonati; Antonello Leone; Salvatore Martellucci; Andrea Gallo; Roberto Albera; Sergio Lucisano; Maurizio Bavazzano; Giuseppe Chiarella; Pasquale Viola; Francesco Galletti; Francesco Freni; Francesco Ciodaro; Vincenzo Marcelli; Giuseppe Tortoriello; Leonardo Scotto di Santillo; Pasqualina Maria Picciotti; Jacopo Galli; Silvano Vitale; Nicola Quaranta; Giada Cavallaro; Paolo Gamba; Roberto Teggi; Iacopo Cangiano; Mario Faralli; Annalisa Barboni; Aldo Messina; Giusi Graziano
Journal:  Audiol Res       Date:  2022-08-22

3.  Risk of benign paroxysmal positional vertigo in patients with depressive disorders: a nationwide population-based cohort study.

Authors:  Chiao-Lin Hsu; Shih-Jen Tsai; Cheng-Che Shen; Ti Lu; Yao-Min Hung; Li-Yu Hu
Journal:  BMJ Open       Date:  2019-03-30       Impact factor: 2.692

4.  Elevated serum macrophage migration inhibitory factor levels correlate with benign paroxysmal positional vertigo and recurrence events.

Authors:  Hong-Bin Cai; Lei Duan; Ting Tian; Zi-Chao Li; Chong-Chong Zhao; Zhao-Ming Ge
Journal:  Biosci Rep       Date:  2019-08-23       Impact factor: 3.840

5.  Sulforaphane alleviates hypoxic vestibular vertigo (HVV) by increasing NO production via upregulating the expression of NRF2.

Authors:  Liyuan Zhou; Changchen Hu; Yujun Li; Binquan Wang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

6.  The potential role of epigenetic modulations in BPPV maneuver exercises.

Authors:  Kun-Ling Tsai; Chia-To Wang; Chia-Hua Kuo; Yuan-Yang Cheng; Hsin-I Ma; Ching-Hsia Hung; Yi-Ju Tsai; Chung-Lan Kao
Journal:  Oncotarget       Date:  2016-06-14

7.  Presence of Anxiety and Depression Symptoms Affects the First Time Treatment Efficacy and Recurrence of Benign Paroxysmal Positional Vertigo.

Authors:  Wei Wei; Zahra N Sayyid; Xiulan Ma; Tian Wang; Yaodong Dong
Journal:  Front Neurol       Date:  2018-03-21       Impact factor: 4.003

8.  Serum levels of superoxide dismutases in patients with benign paroxysmal positional vertigo.

Authors:  Jing Li; Rui Wu; Bin Xia; Xinhua Wang; Mengzhou Xue
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

9.  Review of the pathology underlying benign paroxysmal positional vertigo.

Authors:  Sertac Yetiser
Journal:  J Int Med Res       Date:  2019-12-29       Impact factor: 1.671

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.